Hepatitis A vaccination

Hepatitis A is an important public health issue worldwide. Hepatitis A vaccine (HepA) was first licensed in 1992. Both inactivated HepA (HepA-I) and live attenuated HepA (HepA-L) are highly immunogenic and well tolerated, and immune protection postvaccination can persist for at least 20 y. HepA is e...

Full description

Saved in:
Bibliographic Details
Published inHuman vaccines & immunotherapeutics Vol. 16; no. 7; pp. 1565 - 1573
Main Author Zhang, Li
Format Journal Article
LanguageEnglish
Published United States Taylor & Francis 02.07.2020
Taylor & Francis Group
Subjects
Online AccessGet full text

Cover

Loading…